Exagen Diagnostics Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Exagen Diagnostics Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6411
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:32
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Exagen Diagnostics Inc (Exagen) is a medical device company that offers diagnostic tools. The company provides clinical tools for diagnosis, monitoring and prognosis of autoimmune connective tissue disease. Its products are used for therapeutic drug monitoring of hydroxychloroquine in whole blood and methotrexate polyglutamates, risk assessment testing, anti-TNF monitoring to individualize therapy and optimize dosing, and others. Exagen offers avise ctd, avise sle prognostic, avise infliximab and avise adalimumab, avise hcq, and avise mtx. The company serves physicians and patients. It operates in Vista and Albuquerque, the US. Exagen is headquartered in Vista, California, the US.

Exagen Diagnostics Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Exagen Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Exagen Diagnostics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Exagen Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Exagen Diagnostics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Exagen Diagnostics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Exagen Diagnostics Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Exagen Diagnostics Raises USD23 Million in Series F Financing 10
Exagen Diagnostics Raises USD3.8 Million in Venture Financing 11
Exagen Diagnostics Raises USD1.3 Million in Venture Financing 12
Exagen Diagnostics Raises USD1.5 Million in Venture Financing 13
Exagen Diagnostics Raises USD1 Million in Venture Financing 14
Exagen Diagnostics Raises USD1 Million in Venture Financing 15
Exagen Diagnostics Raises USD1 Million in Venture Financing 16
Exagen Diagnostics Raises USD1 Million in Venture Financing 17
Exagen Diagnostics Raises USD1 Million in Venture Financing 18
Exagen Diagnostics Raises USD1 Million in venture financing 19
Exagen Diagnostics Raises USD2 Million in Venture Financing 20
Exagen Diagnostics Raises USD16.81 Million in Venture Financing 21
Exagen Diagnostics Raises USD3 Million in Venture Financing 22
Exagen Diagnostics Raises USD2 Million in Venture Financing 23
Exagen Diagnostics Raises USD4 Million in Venture Financing 24
Exagen Diagnostics Raises US$5 Million In Venture Financing 25
Exagen Diagnostics Raises US$0.12 Million In Venture Financing 26
Exagen Raises US$5.3 Million In Venture Financing 27
Exagen Diagnostics Inc – Key Competitors 28
Exagen Diagnostics Inc – Key Employees 29
Exagen Diagnostics Inc – Locations And Subsidiaries 30
Head Office 30
Other Locations & Subsidiaries 30
Recent Developments 31
Product News 31
Oct 31, 2017: Exagen Diagnostics Featured in Five Scientific Posters at 2017 ACR/ARHP Annual Meeting in San Diego 31
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32

List of Tables
Exagen Diagnostics Inc, Medical Equipment, Key Facts 2
Exagen Diagnostics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Exagen Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Exagen Diagnostics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Exagen Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Exagen Diagnostics Inc, Deals By Market, 2012 to YTD 2018 8
Exagen Diagnostics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Exagen Diagnostics Raises USD23 Million in Series F Financing 10
Exagen Diagnostics Raises USD3.8 Million in Venture Financing 11
Exagen Diagnostics Raises USD1.3 Million in Venture Financing 12
Exagen Diagnostics Raises USD1.5 Million in Venture Financing 13
Exagen Diagnostics Raises USD1 Million in Venture Financing 14
Exagen Diagnostics Raises USD1 Million in Venture Financing 15
Exagen Diagnostics Raises USD1 Million in Venture Financing 16
Exagen Diagnostics Raises USD1 Million in Venture Financing 17
Exagen Diagnostics Raises USD1 Million in Venture Financing 18
Exagen Diagnostics Raises USD1 Million in venture financing 19
Exagen Diagnostics Raises USD2 Million in Venture Financing 20
Exagen Diagnostics Raises USD16.81 Million in Venture Financing 21
Exagen Diagnostics Raises USD3 Million in Venture Financing 22
Exagen Diagnostics Raises USD2 Million in Venture Financing 23
Exagen Diagnostics Raises USD4 Million in Venture Financing 24
Exagen Diagnostics Raises US$5 Million In Venture Financing 25
Exagen Diagnostics Raises US$0.12 Million In Venture Financing 26
Exagen Raises US$5.3 Million In Venture Financing 27
Exagen Diagnostics Inc, Key Competitors 28
Exagen Diagnostics Inc, Key Employees 29
Exagen Diagnostics Inc, Other Locations 30

List of Figures
Exagen Diagnostics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Exagen Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Exagen Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Exagen Diagnostics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Exagen Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Exagen Diagnostics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Exagen Diagnostics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Exagen Diagnostics Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Exagen Diagnostics Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Financial and Strategic SWOT Analysis Review
    Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportuni …
  • Targovax ASA (TRVX):製薬・医療:M&Aディール及び事業提携情報
    Summary Targovax ASA (Targovax) is a developer and commercializer of immunotherapies for the treatment of cancer patients. The company’s lead candidates include TG0, a peptide-based therapeutic anti-cancer vaccine under development for pancreatic cancer; and ONCOS-102 is an adenovirus-based pipeline …
  • OSE Immunotherapeutics (OSE):製薬・医療:M&Aディール及び事業提携情報
    Summary OSE Immunotherapeutics (OSE), formerly OSE Pharma SA is a biotechnology company that discovers and develops immunotherapy products against invasive and metastatic late-stage cancers. The company’s memopi technology is employed in studying the development of treatments for ovarian, colon and …
  • Velvet Energy Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Velvet Energy Ltd (Velvet Energy) is an oil and gas exploration company that explores and develops oil and liquid-rich natural gas from its assets. The company’s exploration and development operation assets are located in Deep Basin in West-Central Alberta. It produces 17,000 barrels of oil …
  • Salt Lake Potash Ltd (SO4):企業の財務・戦略的SWOT分析
    Summary Salt Lake Potash Ltd (Salt Lake Potash), formerly Wildhorse Energy Ltd, is a mining and mineral exploration and development company that develops and evaluates underground coal gasification projects and uranium deposits. The company operates exploration and mining activities with geographic …
  • Qatar General Electricity and Water Corporation:企業の戦略的SWOT分析
    Qatar General Electricity and Water Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competito …
  • TAXIS Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary TAXIS Pharmaceuticals Inc (TAXIS Pharma) is a healthcare products company that offers drug discovery services. The company develops and discovers pharmaceuticals targeting infectious diseases. It identifies new classes of antibiotic agents use a novel mechanism of bactericidal action differe …
  • Export Development Canada-エネルギー分野:企業M&A・提携分析
    Summary Export Development Canada (EDC) is an export credit agency that provides financial services. The agency supports and promotes Canada’s export trade by providing finance and insurance solutions to companies with export contracts. It provides guarantees to banks to provide their exporting cust …
  • Tenaga Nasional Berhad (TENAGA):企業の財務・戦略的SWOT分析
    Tenaga Nasional Berhad (TENAGA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Taejoon Pharm Co Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Taejoon Pharm Co Ltd (Taejoon) is a pharmaceutical company that markets ophthalmic agents and other drugs. The company offers injections, powders, eye drops, spray, syrups, tablets, soft capsules, liquids for external use, and hard capsules. Its powder products comprise coolprep powder, taej …
  • Perma-Fix Environmental Services Inc (PESI):企業の財務・戦略的SWOT分析
    Perma-Fix Environmental Services Inc (PESI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key streng …
  • The Warehouse Group Ltd (WHS):企業の財務・戦略的SWOT分析
    The Warehouse Group Ltd (WHS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Love’s Travel Stops & Country Stores Inc:企業の戦略・SWOT・財務情報
    Love’s Travel Stops & Country Stores Inc - Strategy, SWOT and Corporate Finance Report Summary Love’s Travel Stops & Country Stores Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Ricoh Imaging Co Ltd:企業の戦略的SWOT分析
    Ricoh Imaging Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Petoro AS:企業の戦略的SWOT分析
    Petoro AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • SSA Marine Inc:企業の戦略的SWOT分析
    SSA Marine Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Ypsomed Holding AG (YPSN):企業の財務・戦略的SWOT分析
    Ypsomed Holding AG (YPSN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Cholamandalam Investment and Finance Company Ltd (CHOLAFIN):企業の財務・戦略的SWOT分析
    Cholamandalam Investment and Finance Company Ltd (CHOLAFIN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the comp …
  • CTI Engineering Co Ltd:企業の戦略・SWOT・財務情報
    CTI Engineering Co Ltd - Strategy, SWOT and Corporate Finance Report Summary CTI Engineering Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Guangzhou Boji Medical & Biotechnological Co Ltd (300404):製薬・医療:M&Aディール及び事業提携情報
    Summary Guangzhou Boji Medical & Biotechnological Co Ltd (BOJI) is a contract research organization. The organization provides services including regulatory affairs, preclinical research, clinical trials I-IV, PMS, clinical trial for medical devices, post marketing studies (PMS), data management and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆